XML 46 R33.htm IDEA: XBRL DOCUMENT
v3.22.4

GENERAL (Narrative) (Details) - USD ($) $ in Thousands |  | 12 Months Ended |
--- | --- | --- | ---
Aug. 05, 2013 | Dec. 31, 2022 | Nov. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract] |  |  |
Upfront payment received | $ 10,000 | $ 10,000 |
Potential milestone compensation | 250,000 | 200,000 |
Preclinical milestone compensation | $ 23,200 |  |
Amount of investment in Compugen |  | $ 12,000 | $ 20,000

X
- Definition Potential milestone revenue from arrangements for research and development, including collaboration and licenses agreements. + References No definition available. + Details
Name: | cgen_ResearchAndDevelopmentArrangementPaymentsReceivable
Namespace Prefix: | cgen_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Potential milestone revenue for preclinical stages of research from arrangements for research and development, including collaboration and licenses agreements. + References No definition available. + Details
Name: | cgen_ResearchAndDevelopmentArrangementPreclinicalPaymentsReceivable
Namespace Prefix: | cgen_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Nominal or face amount on the investment owned. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 20 -Section 10 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=6438156&loc=d3e57880-113973 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 10 -Paragraph 1 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=6431724&loc=d3e32938-113948 + Details
Name: | us-gaap_InvestmentOwnedUnderlyingFaceAmountAtMarketValue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- References No definition available. + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of compensation earned (contract income) under a research and development arrangement accounted for as a contract to perform research and development for others. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 730 -SubTopic 20 -Section 50 -Paragraph 3 -URI https://asc.fasb.org/extlink&oid=6420387&loc=d3e23221-108380 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 730 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=6420387&loc=d3e23199-108380 + Details
Name: | us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration